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Mechanisms for lyssavirus 
persistence in non-synanthropic 
bats in Europe: insights from a 
modeling study
Davide Colombi1,2, Jordi Serra-Cobo3, Raphaëlle Métras  4,5, Andrea Apolloni5,6, 
Chiara Poletto7, Marc López-Roig3, Hervé Bourhy8 & Vittoria Colizza7
Bats are natural reservoirs of the largest proportion of viral zoonoses among mammals, thus 
understanding the conditions for pathogen persistence in bats is essential to reduce human risk. 
Focusing on the European Bat Lyssavirus subtype 1 (EBLV-1), causing rabies disease, we develop a data-
driven spatially explicit metapopulation model to investigate EBLV-1 persistence in Myotis myotis and 
Miniopterus schreibersii bat species in Catalonia. We find that persistence relies on host spatial structure 
through the migratory nature of M. schreibersii, on cross-species mixing with M. myotis, and on survival 
of infected animals followed by temporary immunity. The virus would not persist in the single colony 
of M. myotis. Our study provides for the first time epidemiological estimates for EBLV-1 progression in 
M. schreibersii. Our approach can be readily adapted to other zoonoses of public health concern where 
long-range migration and habitat sharing may play an important role.
Bats are reservoir hosts of a large number of zoonotic viral infections, including some of the recently emerged 
severe infectious diseases affecting humans1–4. They are implicated as reservoirs and vectors for transmission of 
severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses, Ebola 
and Marburg filoviruses, lyssaviruses, Hendra and Nipah viruses1,2,4. Recently a novel lineage of influenza A virus 
was discovered in bats in Central America5. A comprehensive analysis of known mammal-virus associations 
determined that bats harbor a significantly larger proportion of zoonoses compared to all other mammalian 
orders6. Pathogen spillovers from bats to domestic animals and humans may thus represent a serious threat to 
public health, biodiversity and global security7. For this reason, considerable scientific and public health interest 
is invested into identifying the mechanisms and conditions for cross-species transmission leading to a potential 
pandemic episode8,9. A key step to reach this goal and reduce the risk for humans from pathogens of bat-origin 
requires the understanding of how bat ecology may influence the infectious disease dynamics, and thus elucidat-
ing those aspects that are most critical to the circulation of viruses in bats.
A number of studies have proposed that bats have unique ecological, social, and immunological traits increas-
ing their potential to host zoonotic viruses, however given the large variety of host and pathogen species and 
the paucity of wildlife data important gaps still remain2,10. Here we focus on lyssaviruses (Rhabdoviridae family, 
Lyssavirus genus), the agents of rabies diseases. Bats are considered to be the ancestral hosts of lyssaviruses, before 
the viruses progressively diverged from this common ancestor to many recipient host species11–13. To date, bats 
were found to serve as reservoirs of 15 of the 17 lyssavirus species currently known14,15. In Europe, four different 
lyssavirus species have been isolated in bats, namely European bat lyssavirus types 1 and 2 (EBLV-1 and EBLV-2, 
respectively), Bokeloh bat lyssavirus (BBLV), West Caucasian bat virus (WCBV) and one tentative species, Lleida 
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bat lyssavirus13,16–19. Reported in Europe for the first time in 195420, EBLV-1 is the most commonly found spe-
cies in the continent with a wide distribution across Germany, the Netherlands, Denmark, France, Spain16,20–24. 
It has the potential to cross the species barrier and infect other domestic and wild mammals20,22,25,26, as well as 
humans19,24,27, where it causes fatal encephalitis, indistinguishable from other lyssaviruses.
Relatively little is known about the dynamics of EBLV-1 infection in European bats and the conditions for viral 
transmission and maintenance. Routine programs of passive surveillance were established in Europe at the end of 
the 80′s to study the distribution, abundance, and epidemiology of lyssavirus infections in bats. The vast majority 
of EBLV-1 positive cases was found to be associated with the Serotine bat (Eptesicus serotinus)19,20,28, a largely 
diffused species in the Eurasian region that almost exclusively roost in buildings close to suburban areas, i.e. dis-
playing a synanthropic behavior. Retrospective investigations of passive surveillance data and reports from active 
surveillance studies provided however evidence of EBLV-1 circulation (through neutralizing antibodies, viral 
RNAs) in other bat species20,29–35, including Myotis myotis in France30, Belgium32 and Spain33–35, and Miniopterus 
schreibersii in France30 and Spain33–35.
M. schreibersii may be particularly important for the spatial diffusion and maintenance of EBLV-1 in European 
bats. Sequence analyses of EBLV-1 genomes from nine European countries indeed uncovered the geographic sep-
aration between phylogeographical clusters of EBLV-1 variants that cannot be fully explained by the geographic 
distribution of E. serotinus36, a sedentary bat species37. Other bat species are thought therefore to be implicated 
in EBLV-1 circulation, with migratory species potentially assuming a prominent role in carrying the pathogen 
across different host populations at distant areas38.
In addition to high mobility, the social nature of bats and their colonial aggregation constitute ideal driv-
ers for viral exchange and dispersal39. Colony size and species richness were found to be associated with an 
increased EBLV-1 seroprevalence in Spanish bats33,35. Population density and proximity of bats in the same cave 
provide indeed higher chances for mixing and transmission between individuals. A large number of species in 
the same roost might not only increase the rates of contact between bat populations, but also provide paths for 
cross-species diffusion and subsequent seeding events in other caves thanks to individual mobility. This suggests 
that infection cycles may be maintained among different host species, facilitating transient epidemics through 
extinction and recolonization events in a spatially structured environment, and overall potentially contributing 
to the spatial circulation of the virus at the regional scale.
Disease progression within individual hosts remains undefined, however it is expected to account for mech-
anisms to escape lethal infection and replenish the population of susceptible individuals to sustain transmission, 
contrasting the characteristic long lifespan of bats. Findings from passive and active surveillance suggest that 
bats may be capable of being exposed to lyssaviruses without dying29. No evidence has however addressed so 
far this aspect in a satisfactory or definitive way, mainly because of the scarce available knowledge on bat immu-
nology40. Experimental infections in the primary host of EBLV-1 highlighted a strong dependence of the effi-
ciency of transmission and probability of causing rabies disease on the virus transmission route41. The absence of 
virus-neutralizing activity in all sera under all transmission conditions is however in sharp contrast with field data 
from Spain, France, and Germany25,30,33,35,42. The presence of EBLV-1 neutralizing antibody response in healthy 
individuals appears to be relatively common and have been documented in E. serotinus and in other bat species 
including M. myotis and M. schreibersii in various regions30,33,35,42,43. While its interpretation remains rather dif-
ficult, previous work suggested this response may result from bats recovering from the infection following EBLV 
exposure30. Direct evidence of transmission during abortive or subclinical infection under natural conditions is 
indeed difficult to achieve with active surveillance as lyssaviruses are excreted only for short periods25,30. A recent 
longitudinal survey of E. serotinus colonies in France42 found for the first time viral RNA in bats saliva concom-
itant with virus excretion, and later followed by seropositivity, suggesting that transmission may occur during 
subclinical infection. In addition, individual waves of seroconversion and waning of immunity were reported in 
the same colony, similar to previous results obtained for M. myotis in Spain44.
Where knowledge gaps in bat ecology, epidemiology, and immunology hinder a comprehensive assessment of 
the mechanisms for EBLV-1 persistence in European bats, mathematical models provide a synthetic framework 
for hypotheses testing that can help improve our understanding of the spatial patterns reported by observational 
studies and identify important drivers for persistence. Such cross-disciplinary integrative modeling was previ-
ously suggested as a relevant research avenue to provide additional insights into the infectious disease dynamics 
with implications for our understanding of zoonotic disease emergence and associated risk for humans2. Here 
we develop a data-driven mechanistic metapopulation model for EBLV-1 spatial diffusion in the Miniopterus 
schreibersii and Myotis myotis non-synanthropic bat species in a system of caves in Catalonia, a region in the 
North-East of Spain. The model builds on existing data from a long-term field survey of EBLV-1 infection in 
natural bat colonies in the region33,35,38. M. myotis live as a single colony of few hundred individuals in the cave 
called Can Palomeres. M. schreibersii is a regional migratory species following a complex annual migration from 
cave to cave in the region. The two species share the same habitat in Can Palomeres during summer months. 
Through the use of spatially-resolved demographic and migration data, we explore several hypotheses regarding 
unknown epidemiological (transmission potential), immunological (lethal infection, immunity) and ecological 
aspects (cross-species mixing, seasonality in mixing, migratory behavior) to identify the mechanisms responsi-
ble for the reported EBLV-1 persistence in the two species. Given the current limitations of global surveillance 
for zoonotic diseases, focusing on the dynamics of bat infectious diseases and improving our understanding of 
the mechanisms driving their persistence may provide useful information to complement the available scarce 
resources to predict epizootics and potential risk for humans.
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Results
EBLV-1 metapopulation model design. We develop a multi-species metapopulation epidemic model45–47 
where shelters occupied by bats are represented by patches and migration events between shelters are represented 
by links connecting different patches. After hibernation in Avenc Davi (AD), M. schreibersii population splits 
between northern and southern migration routes (Fig. 1a) for mating, birthing and breeding during spring and 
summer seasons, before reuniting itself in Avenc Davi at the start of the fall (Fig. 1b). M. myotis bats constitute 
a single colony located in Can Palomeres (CP) year-round where they may get in contact with M. schreibersii 
throughout spring/summer months.
Host mixing and possible local transmission of infection occurs within each populated patch. We propose 
three models for EBLV-1 infection dynamics in the bat species under study, to account for different hypotheses 
based on field observations and experimental knowledge. They are all based on a susceptible-exposed- 
Figure 1. Schematic representation of the spatial model. (a) Schematic georeferenced diagram of the 
metapopulation model, composed of roosting caves (nodes) and migratory path (links) for M. schreibersii 
in the region of Catalunya. Can Palomeres is the cave where cross-species mixing may occur. (b) Temporal 
representation of the annual seasonal migration of M. schreibersii. Cave occupation is represented with filled 
rectangles (northern route) and striped ones (southern route).
Figure 2. Disease progression models and seasonality of transmission. (a) Compartmental structure for model 1, 
where no infection-induced mortality is considered and immunity wanes with rate ω. εI is the rate of becoming 
infective following infection, and μ the recovery rate (b) Compartmental structure for model 2, considering 
lethal infection to occur with probability ρ, whereas non-lethally exposed individuals (ER) recover with rate εR to 
the permanently immune state. (c) As in (b) for model 3, where immunity wanes with rate ω. Demographic 
processes in the three diagrams are omitted for clarity. (d) Reproductive numbers R p0  for M. schreibersii along 
each patch p of the migration path. The values correspond to the maximum likelihood estimates. The average 
reproductive number of the metapopulation model, ⟨ ⟩R0 , is also shown (black dashed curve).
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infected-recovered (SEIR) compartmental scheme48, with variations to account for different immunological 
responses. Model 1 assumes non-lethal infection and loss of immunity (panel a of Fig. 2), as done in previous 
modeling works44,49. Model 2 considers the possibility for bats to develop a lethal infection (with a given proba-
bility ρ = . . .0 15, 0 35, 0 5), alternative to a non-infectious state followed by permanent immunity (panel b). 
Model 3 is a variation of model 2 that considers temporary immunity of average duration ω−1 (panel c).
Seasonality characterizes migrations flows, hosts’ birth, and also transmission intensity, as the latter varies 
upon the degree of bats activity throughout the year. For M. schreibersii, we model it through a patch-dependent 
variation of the reproductive number R0 (Fig. 2d and Methods), a key epidemiological parameter measuring the 
average number of secondary cases that an infectious host can generate during the infectious period in a fully 
susceptible population50. For M. myotis, we consider a two-step function for R0 describing hibernation in win-
ter months (as for M. schreibersii in Avenc Davì) and breeding and mating during the rest of the year (as for M. 
schreibersii in Can Palomeres).
Cross-species transmission between M. schreibersii and M. myotis may occur in Can Palomeres only where the 
two species share the habitat. We model it with a reduction in transmissibility, α=R Rmix CP0 0  with α≤ ≤0 1, to 
account for reduced mixing between different species (α = 0 refers to non-mixing conditions).
All parameters are described in Methods and Table S5 of the Supplementary Information.
Predicted EBLV-1 persistence. We compute the persistence probability of EBLV-1 in each bat species as 
the fraction of stochastic simulations reaching the endemic equilibrium in both host populations, by varying the 
input reproductive number in Can Palomeres, . ≤ ≤ .R1 1 3 1CP0 , and the M. schreibersii average immunity period, 
ω≤ ≤−180 7801 . We compare numerical results across different models and hypotheses by introducing a meta-
population summary measure for M. schreibersii given by the average reproductive number of the metapopula-
tion model across time and patches:
Figure 3. Persistence probability of EBLV-1 in M. schreibersii and in M. myotis bats in model 1. (a,b) 
Persistence probability for M. schreibersii (a) and for M. myotis (b) as a function of the average reproductive 
number of the metapopulation model ⟨ ⟩R0  and of the immunity period ω−1 in the mixing scenario. (c,d) as in 
(a,b) in the non-mixing conditions. Contour lines indicate a persistence probability of 80%. The dashed 
horizontal line refers to =⟨ ⟩R 10 . Solid horizontal lines refer to threshold conditions ( =R 1p0 ) for the caves.
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where R p0  represents the reproductive number of patch p, and Np(t) indicates the M. schreibersii population size of 
patch p at time t.
EBLV-1 circulation in both species is numerically recovered only in model 1 (temporary immunity and 
non-lethal infection) with cross-species mixing (Fig. 3, panels a and b). The absence of mixing between M. schreibersii 
and M. myotis or lethal infection lead instead to negligible or null probability of persistence in one of the species 
Reproductive number Maximum likelihood estimate and 95% CI
⟨ ⟩R0 1.02 [0.91–1.18]
R CP0 1.6 [1.43–1.84]
R OC0 1.24 [1.11–1.43]
R C0 1.06 [0.96–1.23]
R SR0 1.06 [0.96–1.23]
R AD0 0.53 [0.48–0.61]
Table 1. Maximum likelihood estimates for the reproductive number.
Figure 4. Comparison with experimental scenarios. Persistence probability for M. schreibersii as a function of 
the average reproductive number of the metapopulation model ⟨ ⟩R0  for values of the immunity period ω−1 
spanning the estimated confidence interval. Each experimental scenario indicated in the plot title is compared 
with the reference model, corresponding to the data-driven metapopulation model. Numerical results are 
obtained for model 1 in mixing conditions. The dashed vertical line indicates =⟨ ⟩R 10 .
www.nature.com/scientificreports/
6ScIentIfIc REPORtS |           (2019) 9:537  | DOI:10.1038/s41598-018-36485-y
(M. myotis, Fig. 3, panel d) or both (Table S6 of the Supplementary Information, for different probabilities leading 
to the lethal infectious state), respectively. Also, density-dependent transmission would not allow persistence of 
the pathogen in any of the models explored (Table S6).
Persistence probability profiles are very similar in the two host populations in model 1 with cross-species mix-
ing. Virus circulation is maintained for all values of the immunity periods explored, with high persistence ensured 
at lower transmissibilities if the immunity period is short. Mixing allows persistence also for values of the average 
metapopulation reproductive number close to or below the critical threshold, favoring viral circulation compared 
to the non-mixing case (Fig. 3, panels a and c).
We performed a sensitivity analysis to allow for variations in the ecological estimates (bat population sizes, 
Figs S4 and S5 of the Supplementary Information; starting date of migration events, Fig. S6; duration of migration 
events, Fig. S7), and in the assumed length of the infectious period (Fig. S3) yielding no variation in the predicted 
conditions for EBLV-1 circulation in both species.
Maximum likelihood analysis. We use a maximum likelihood approach to compare the seroprevalence 
data from the two species51 with numerical results of model 1 and identify values of the reproductive number and 
immunity period mostly compatible with observations (see details in the Supplementary Information). Best esti-
mate values for the unknown parameters are ω−1 = 390 (95% CI: 228–772) days and = .R 1 6CP0  (95% CI: 1.43–
1.84). The latter is associated to a metapopulation average just above the critical threshold, = .⟨ ⟩R 1 020  (95% CI: 
0.91–1.18), whereas the reproductive number is predicted to be largely subcritical in Avenc Davi during the 
hibernation period, R AD0  = 0.53 (95% CI: 0.48–0.61) (Table 1). With R
CP
0  set to its maximum likelihood estimate, 
we find the probability of viral persistence in M. schreibersii to vary strongly, decreasing from 82% to 1% when the 
immunity period varies within its 95% confidence interval, with a probability equal to 38% for the best estimate 
ω−1 = 390 days (Fig. S1 in the Supplementary Information). Such trend in the persistence probability is not sub-
stantially altered by variations in the assumed values for cross-species mixing (Fig. S2).
Experimental scenarios. To assess the impact of several ecological drivers on the probability of persistence 
of EBLV-1 in both species, we compare our data-driven metapopulation model with a set of experimental scenar-
ios (see Methods).
Discarding yearly seasonality of transmission and keeping a reproductive number constant in space and time 
leaves the persistence probability almost unaltered (non-seasonal metapopulation, Fig. 4). The essential role of 
migration is ensured by its northern portion, without which the likelihood of viral maintenance would be strongly 
reduced for a large set of values of 〈 〉R0 , becoming null when 〈 〉R0  assumes its maximum likelihood estimate 
(northern path only vs. southern path only). Finally, considering the breakdown of the Summer refuges patch into 
smaller subpopulations, i.e. through a higher spatial resolution metapopulation model, would require a slight 
increase in transmissibility to reach the same persistence values of the reference model (higher resolution).
Discussion
Through a spatially explicit multispecies metapopulation model based on available data from a long-term field 
survey on M. schreibersii and M. myotis bats in Spanish natural colonies, our study identified the main drivers for 
EBLV-1 persistence in the ecosystem under study and provide novel numerical evidence informing on previously 
unknown epidemiological, immunological and ecological factors.
Overall our findings indicate that EBLV-1 persistence relies on host spatial structure through the migration 
of M. schreibersii bats, on cross-species mixing with M. myotis population, and on a disease progression leading 
to survival of infected animals followed by temporary immunity. Even a low probability of developing lethal 
infection together with bats migration and reseeding through cross-species mixing would not be able to sustain 
the epidemic, regardless of the loss of immunity. While Lyssavirus infections are known to be generally lethal for 
mammals and for some bat species52,53, current knowledge from experimental and natural studies is not sufficient 
to accurately and satisfactorily define EBLV-1 disease progression in bats in natural conditions30,33,35,40,42,43. This 
is further complicated by biological and regulatory aspects. First, despite recent evidence for E. serotinus bats in 
France42, detecting a subclinical infective state in healthy bats in natural colonies is rather unlikely because of the 
short duration of the excretion period, and no such evidence exists yet for M. schreibersii or M. myotis. Second, 
the legal framework protecting European bats54 makes field studies particularly difficult to implement, as for 
instance marking bats is forbidden in Europe and special authorizations need to be requested to conduct these 
studies. Little but precious available field data are providing however an increasing body of evidence pointing to 
the possibility that various bat species may experience an infective subclinical state after being exposed to EBLV-
1, followed by recovery and loss of immunity, with no associated increased mortality25,30,35,42,44, in agreement with 
our model results. A constant survival rate despite recurrent EBLV-1 epidemic cycles was reported for M. myotis44, 
supporting the findings of our model. Additional field data is needed to confirm our numerical predictions on 
EBLV-1 infection in M. schreibersii.
Two ecological factors emerge as critical drivers for viral persistence: cross-species mixing and host migra-
tion. We found that EBLV-1 circulation would not be maintained in a single colony alone in absence of mixing 
with other species. Multi-species colonies are indeed a phenomenon largely observed in the field that is known 
to favor virus exchange33,55. The importance of cross-species transmission of lyssaviruses was also reported in 
other ecological settings, identifying phylogenetic distance as the key determinant for cross-species transmission 
of rabies virus in North American bat species11,56. No study of this kind has been performed yet on EBLV-1 hosts 
species, and while the mixing intensity between M. schreibersii and M. myotis in Can Palomeres is unknown, our 
persistence estimates remain quite robust against this assumption. Our findings suggest that an increased public 
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health attention should be focused on caves hosting multiple bat species with targeted surveillance and ecological 
fieldwork to improve our understanding of the role of species richness in viral exchange.
We find that transmission may not depend on host density in the cave. Many bat species are indeed known 
to form communities (families) that are stable over short terms (daily and nocturnal activities) and long terms 
(between migrations) thus including members of different generations, and whose sizes are independent on the 
colony size57,58. Given that virus transmission through bites and scratches41 requires close contact, the regularity 
of interactions with a limited number of hosts may explain the frequency-dependent transmission selected by 
our model. This result however seems to depend considerably on the species considered and the roosting behav-
ior59. Additional modeling work focusing on different contexts might help better understanding such dependence 
across different conditions.
The other component critical for stable EBLV-1 circulation is the presence of the migratory species. 
Movements of infected individuals provide a mechanism for maintaining the chains of transmission through 
the seeding of epidemics in different patches. The importance of frequent immigration of infected hosts for per-
sistence was also recognized in other settings49,51,60,61. Moreover, our findings indicate that the migratory species 
may contribute to pathogen persistence in species encountered along the migratory path. Given the potential for 
long-range seasonal movements of M. schreibersii35,38, this species may represent a central vector for spatial dis-
persion of EBLV-1 in southern Europe, where this bat species is abundant, possibly contributing to reconcile the 
discrepancy observed between the phylogeographical clusters of EBLV-1 variants and the geographic distribution 
of its common host species E. serotinus36.
In the ecological context under study, the northern portion of the migratory path is entirely responsible for 
viral persistence at the estimated immunity waning, likely because it is composed by a more complex spatial 
structure including a larger number of patches, thus creating more opportunities for seeding events sustaining 
coupled but non-synchronous patch epidemics62 that cannot be otherwise obtained with the southern path only. 
Increasing spatial resolution and resolving shelters sharing similar ecological and environmental conditions (such 
as the ones collectively grouped in Summer refuges) would not substantially alter our predictions. These findings 
are important to inform future field studies minimizing data collection efforts on roosts occupation.
Seasonality in mixing between hosts was instead found to have a negligible impact on EBLV-1 maintenance, 
suggesting that field efforts should be prioritized to provide an accurate characterization of the migration pattern, 
an important driver for EBLV-1 endemic circulation, instead of hosts’ degree of interaction.
The maximum likelihood analysis allows us to provide for the first time previously unidentified parameters 
characterizing the disease dynamics of EBLV-1 in M. schreibersii. We find that transmission among M. schreibersii 
bats in Can Palomeres (i.e. under the highest mixing conditions) is similar to what was previously estimated for 
M. myotis (R0 = 1.7) in natural colonies in Spain44. These conditions of transmissibility are associated to other 
caves being in close-to-critical or sub-critical conditions for efficient epidemic transmission. Persistence is thus 
mainly supported by transmission in Can Palomeres, though this cave only is not sufficient to maintain endemic-
ity in M. myotis. The modeling predictions for the M. schreibersii immunity period are in the ballpark of previous 
empirical estimates of the maximum length of seropositive status observed in M. myotis (2–3 years)35 and in E. 
serotinus (4 years)42. Individuals are predicted to be immune on average for more than a year, thus hindering 
virus survival because of the slow replenishment of susceptible hosts. This effect is however counterbalanced by 
the migration of hosts that occurs on an annual timescale, providing opportunities for seeding events in naïve 
populations, a mechanism already identified by theoretical works to sustain viral circulation62. A rather large con-
fidence interval is obtained for the estimate of the immunity period, indicating that the available serological data 
are not sufficient to significantly discriminate between approximately 1 year and 2 years of duration of immunity. 
Also, the likelihood of persistence is predicted to vary quite considerably within this range, as the system is found 
in the transition between null or negligible persistence and very high probability of viral maintenance. Additional 
cross-sectional studies in this colony and at higher temporal resolution may help improve our estimates.
The robustness of our model to a set of ecological, epidemiological, and immunological assumptions high-
lights that, despite the very limited knowledge of the system, our data-driven approach is able to clearly identify 
the mechanisms underpinning EBLV-1 circulation in the studied populations, contributing to the interpretation 
of field and laboratory data as well as providing important information for prioritizing and planning further 
empirical investigations.
Our study provides an example of how models can yield powerful insights for the identification of the main 
aspects of host ecology and interaction with the pathogen driving the maintenance of the infection in the host 
population. Though focused on a single ecological and epidemiological context, our model may be applied to 
other contexts of zoonotic interest through appropriate parameterizations, in order to derive insights into the 
infectious disease dynamics in bat populations and improve our understanding of the risk of transmission to 
domestic animals and humans. For instance, through a comparative approach across bat species and lyssavi-
rus types, it may become possible to isolate host-pathogen specific drivers (e.g. the difference in pathogenicity 
between bats hosting rabies virus59 and EBLV-1) from commonalities (such as spatial structure and introduc-
tions) that would represent the key mechanisms for disease persistence across a range of lyssavirus systems. 
Understanding those, as well as the impact of possible anthropogenic changes on the infection dynamics in bats 
(e.g. a cave refuge for bats transformed into a touristic park), is essential for assessing bats capacity to serve as lys-
savirus reservoirs in different geographic areas of the world and predicting the associated pathways for spillover 
events9.
Our study may be extended to other pathogens beyond lyssaviruses. While bats that host filoviruses like Ebola 
and Marburg viruses in Africa display very distinct ecological and behavioral traits compared to the European bat 
species studied here, recent surveillance work in Europe discovered a novel Ebolavirus-like filovirus in dead M. 
schreibersii63. Empirical evidence suggests that it may be pathogenic for the affected population, in contrast with 
the asymptomatic circulation of Ebola and Marburg viruses in fruit and insectivorous bats in Africa64,65. Given the 
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large geographic distribution of M. schreibersii, and the critical role of its migratory behavior for pathogen persis-
tence examined here, the discovery of a novel and potentially deadly filovirus in Western Europe is a significant 
concern. Integrative models may result to be particularly important to explore such scenarios where surveillance 
data is still rather poor, in order to strategize future empirical data collections.
With human-wildlife interactions still difficult to quantify9, considerable attention has shifted to animal pop-
ulations. Spurred by outbreaks of high-impact viral zoonoses causing severe disease in human population, this 
paradigmatic shift has led to a remarkable increase in wildlife disease surveillance for early recognition of poten-
tial threats to humans (e.g. avian influenza in wild birds66, coronaviruses in bats67–69, etc.). Even after controlling 
for confounding factors such as investment in surveillance and research, bats were identified as carrying the 
highest proportion of zoonotic viruses across all mammals6. Moreover, hotspots of missing zoonoses were pre-
dicted for bats in Latin America and some parts of Asia, suggesting that pathogen diversity in bat species may 
be even larger than what currently known. Within such diversity, lyssaviruses still represent the only group of 
pathogens naturally circulating in bats for which a direct causal link between an infected bat and humans is well 
recorded19,24,27,70–83. Though the largest majority of rabid cases in humans is transmitted by rabid dogs, humans 
can develop rabies diseases after contact with a bat infected with a lyssavirus, leading to invariably fatal cases. 
Moreover, accurate human morbidity estimates for infections transmitted by bats are generally hard to achieve 
because standard diagnostic tests cannot readily resolve the causative lyssavirus14. Rabies vaccination is generally 
recommended in specific contexts to prevent and mitigate occupational hazards, often leading to a heavy financial 
burden on public health infrastructure84.
Our study is affected by some limitations. We did not consider E. serotinus bats in our model, the host species 
associated with the large majority of EBLV-1 cases detected in Europe19,20,28. While present in the region under 
study, its synanthropic behavior (i.e. living close to humans populations) likely precluded interactions with M. 
schreibersii and M. myotis, which instead clearly exhibit a non-synanthropic behaviour, roosting in natural caves 
and in abandoned mines35. Moreover, our model considers the two host populations to be closed and isolated 
in the region under study. While contacts with other non-synanthropic bat species of smaller population sizes 
may occur in Can Palomeres, our findings show that 2 host species are enough to self-sustain the epidemic given 
cross-species mixing and 1-species migration, with no need for additional introductions from other sites. This 
may appear to be in contrast with was found in other contexts, e.g. in a rabies virus model in vampire bats where 
persistence was largely dependent on immigration of infected individuals51. Our model however already accounts 
for seeding events from one patch to another thanks to the migration of M. schreibersii. Similarly to the study by 
Blackwood et al., we find indeed that the virus would not be maintained in a single population only.
The uncovered strong spatial component to transmission dynamics may help understanding the observed 
spatial diffusion of the virus at a larger scale on the continent and across a diverse range of host species, through 
long-range migration and seeding of local populations. Given the primary role of bats in carrying the largest 
proportion of zoonotic pathogens across mammals, determining how hosts enable persistence and which host 
species are critical in a multi-host infectious disease setting is essential for disease prevention and control. Our 
framework can readily be extended also to other zoonotic viral pathogens of public health concern circulating in 
spatially dispersed bat populations.
Methods
Migration. Following hibernation in Avenc Davì (AD), M. schreibersii population splits between northern 
and southern migration routes (Fig. 1b). On the northern route, M. schreibersii reach Castanya (C) for mat-
ing, and then they progressively start migrating to Can Palomeres (CP) for mating and birthing. An important 
fraction of the population (estimated 60%) continues the migration further north to other refuges composed 
of breeding or summer colonies (“Summer refuges”, SR, in Fig. 1a), where they stay approximately all summer. 
During the same period, the remaining bats stay in Can Palomeres where they share the refuge with M. myotis. 
Once summer is over, the entire M. schreibersii colony returns to Avenc Davì following the northern route in the 
opposite direction: from Summer refuges to Can Palomeres, to Castanya, to Avenc Daví for hibernation to con-
clude the annual migration. Bats following the southern route from Avenc Daví reach a set of caves near the coast 
(“Other caves”, OC) and return to Avenc Daví for hibernation, reuniting with the bats following the northern 
route. Migration rates are set to estimates from field data (Table S1 of the Supplementary Information)38, and a 
sensitivity analysis on starting date of migration events and on their duration was performed.
EBLV-1 infection and vital dynamics. The three models considered are all a variation of a standard 
SEIR compartmental model, considering transmission in each patch and possible cross-species mixing in Can 
Palomeres. As an example, we provide here the force of infection for M. schreibersii in Can Palomeres in model 1, 
whereas full details for all models are reported in the Supplementary Information:
λ
ε μ
ε
ε μ
ε
=
+ +
+
+ +t R d d I t
N t
R d d I t
N t
( ) ( )( ) ( )
( )
( )( ) ( )
( )
,
(1)
CP I
I
s
s
mix I
I
m
m
0 0
where εI is the rate of becoming infective following infection, μ the recovery rate, d the mortality rate, Is(t) is the 
number of infective M. schreibersii bats in the Can Palomeres population of size Ns(t) at time t, and analogously 
(I t N t( ), ( )m m ) for M. myotis.
We set disease progression parameters for M. myotis to available estimates from previous studies44,49. Lacking 
data characterizing the disease progression of EBLV-1 in M. schreibersii, we set the average durations of the 
incubation and infectious period to the values estimated for M. myotis, following previous modeling work49. 
Variations of these values are then considered for sensitivity analysis.
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Seasonal birth is modeled during birthing summer season in Can Palomeres for both species, and natural 
death rate is assumed constant.
Seasonality in EBLV-1 transmission in M. schreibersii. We consider the reproductive number R CP0  in 
Can Palomeres as an input to the model and corresponding to the highest transmissibility, associated with the 
highest mixing for mating and birthing occurring in that cave. Reproductive numbers in the other patches assume 
smaller values: =R RAD CP0
1
3 0
 in Avenc Davì (i.e. the smallest value during hibernation period) and 
= =R R RC SR CP0 0
2
3 0
 in Castanya and Summer refuges, based on expert opinion. For Other caves along the south-
ern route we make the parsimonious hypothesis of = + +R OC R R R0 3
C CP SR
0 0 0 , equal to the average value of northern’s 
path parameters.
Numerical simulations and persistence analysis. We perform discrete stochastic numerical simula-
tions of the EBLV-1 transmission in the host populations to account for the discrete nature of hosts and for 
stochastic extinction events that may be favored by small host population sizes. Time is considered to be discrete 
with a daily timescale. The epidemic is seeded with 100 infected M. schreibersii bats and 10 infected M. myotis 
bats in the hibernation period, and different initial conditions are explored for sensitivity. For each model and 
under each hypothesis considered, we ran 103 stochastic simulations starting from the same initial conditions and 
reaching the endemic equilibrium. Simulations provide at each time step the number of M. schreibersii and M. 
myotis in each compartment in each cave, and the number of M. schreibersii migrating from one cave to another. 
The metapopulation framework is implemented in C++, and technical details for simulations are reported in the 
Supplementary Information.
Experimental scenarios. To evaluate the role of seasonality in transmission, we build a non-seasonal meta-
population epidemic model with the same spatial structure of the data-driven metapopulation model (i.e. patches, 
demographics and migration dynamics of Fig. 1), but with no variation in the transmissibility associated to the 
caves. The reproductive number is assumed to be constant in time and space, and equal to ⟨ ⟩R0 .
To identify the portions of the migration path that are mostly relevant for disease persistence, we consider 
a northern path only metapopulation model considering only bats following the path including Avenc Davi, 
Castanya, Can Palomeres and Summer refuges, and a southern path only metapopulation model considering 
instead only bats following the path from Avenc Davi to Other caves and return. Time and rates of migration 
events remain as in the full migration path.
To assess the role of spatial resolution in the identification of patches and associated mixing opportunities, 
we consider a higher resolution metapopulation model where all caves in the Summer refuges are independently 
considered as patches (corresponding migration flow estimates are provided in the Supplementary Information).
Finally, we test density-dependent transmission rates for EBLV-1 dynamics in both species, alternative to the 
frequency-dependent assumption considered in Eq. (1), to explore different mixing conditions.
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